37
Participants
Start Date
December 31, 2009
Primary Completion Date
March 31, 2016
Study Completion Date
April 30, 2016
Moroctocog alfa ( AF-CC)
Dosing is at the discretion of the Investigator
Laboratory tests
Factor VIII PK samples, Hematology, Chemistry and Coagulation testing, FactorVIII Inhibitor and Anti Factor VIII antibody
University Children's Hospital, Belgrade
Hospital Universitario Puerta del Mar, Cadiz
"Mother and Child Health Care Institute of Serbia Dr Vukan Cupic", Belgrade
Hospital Jerez de la Frontera, Jerez de la Frontera
Hospital La Paz, Madrid
Ege University Department of Pediatrics, Pediatric Hematology Division, Izmir
Centro di Riferimento Regionale per la cura dell'Emofilia e delle Malattie Emorragiche Congenite, Parma
Hospital Universitario Miguel Servet, Zaragoza
"Komunalna ustanova Zaporizka oblasna klinichna dytiacha likarnia", Zaporizhzhia
Kuopio University Hospital, Kuopio
"Derzhavna ustanova Instytut patolohii krovi ta transfuziinoi medytsyny Natsionalnoi akademii medych", Lviv
Spitalul Clinic Judetean de Urgenta Craiova, Craiova
LTD Medinvesti- Institute of hematology and transfusiology, Tbilisi
Sanador, Bucharest
Karolinska Universitetssjukhuset-Solna, Stockholm
Cukurova University Department of Pediatrics, Pediatric Hematology Division, Adana
Akdeniz Universitesi Tip Fakultesi, Antalya
Lead Sponsor
Pfizer
INDUSTRY